# Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-peficitinib-asp015k-in-patients-with-rheumatoid-arthritis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yoshiya Tanaka,Tsutomu Takeuchi,Sakae Tanaka,Atsushi Kawakami,Manabu Iwasaki,Yeong Wook Song,Yi‐Hsing Chen,James Cheng‐Chung Wei,Sang‐Heon Lee,Mitsuhiro Rokuda,Hiroyuki Izutsu,Satoshi Ushijima,Yuichiro Kaneko,Rio Akazawa,Teruaki Shiomi,Emi Yamada |
| Citations | 111 |
| DOI | 10.1136/annrheumdis-2019-215163 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ard.bmj.com/content/annrheumdis/78/10/1320.full.pdf |
| OpenAlex ID | https://openalex.org/W2965006635 |
| PMID | 31350270 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Yi‐Hsing Chen](https://scholariq.org/researchers/yi-hsing-chen/)

## Paper journal

- [Annals of the Rheumatic Diseases](https://scholariq.org/journals/annals-of-the-rheumatic-diseases/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Natural Compounds in Disease Treatment](https://scholariq.org/topics/natural-compounds-in-disease-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.